ÂÜÀòÂÒÂ×

Brian Dorsey is Senior Vice President of Operations and Project Management at ARS Pharmaceuticals, Inc. He has served in the pharmaceutical and biotechnology industries for more than 20 years providing high-level drug development, regulatory and QC/QA leadership of pharmaceutical candidates from early development through FDA approval.

is a founding partner at MagnaSci Ventures, a healthcare fund focused on investing in early stage life science companies. He is also a founder of Kalyra Pharmaceuticals and Septum Solutions. Prior to joining ARS Pharmaceuticals, Inc., Mr. Dorsey was Chief Development Officer for Apricus BioSciences, a publicly traded biotechnology company.

Mr. Dorsey has also held various senior management positions including Senior Vice President of Research and Development and Chief Compliance Officer of Pernix Therapeutics Holding Inc.; Senior Vice President of Technical Operations and Regulatory Affairs for Somaxon Pharmaceuticals; Head of Project Management, Medical Writing and Library Services at Maxim Pharmaceuticals; Head of Biopharmaceutical Project Management of Baxter Bioscience and Manager of Chemistry, Manufacturing, and Control for Chugai Biopharmaceuticals.

Mr. Dorsey has held several positions within the Agouron / Warner Lambert/ Pfizer organization and has lead development projects in the antiviral, oncology, and ophthalmology therapeutic areas. He was named a Global Project Leader within Pfizer.

He serves on the board of directors for Neurana Pharmaceuticals, Cell Machines, Forward Sciences, Forge Therapeutics and Tao Life Sciences.

Mr. Dorsey received his Master of Science in Executive Leadership and his B.A. in chemistry from the University of San Diego.